|
Cardiac - Anesthesia: |
Back to the top |
None selected this quarter
|
|
Cardiac - Diagnostic: |
Back to the top |
Ejection fraction velocity ratio as an indicator of aortic stenosis severity.
AL-Ghamdi AM, Melendez LJ, Massel D.
Echocardiography 2005;22:195-202.
Noninvasive evaluation of the coronary arteries with multislice computed tomography in hypertensive patients.
Schuijf JD, Bax JJ, Jukema JW, et al.
Hypertension. 2005;45:227-32.
|
|
Cardiac - Monitoring/Transfusion: |
Back to the top |
Comparison of cardiac output determined by bioimpedance, thermodilution, and the Fick method .
Engoren M, Barbee D.
Am J Crit Care 2005 14:17-25.
|
|
Cardiac - Other: |
Back to the top |
None selected this quarter.
|
|
Cardiac-Pharmacology: |
Back to the top |
|
A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass.
Avidan MS, Levy JH, Scholz J, et al.
Anesthesiology 2005;102:276-84.
Calpain inhibition decreases endothelin-1 levels and pulmonary hypertension after cardiopulmonary bypass with deep hypothermic circulatory arrest.
Duffy JY, Schwartz SM, Lyons JM, et al.
Crit Care Med 2005:33:623-28
|
|
Cardiac - Physiology: |
Back to the top |
|
Transfusion-related acute lung injury.
Silliman CC, Ambruso DR, Boshkov LK.
Blood 2005;105:2266-73.
|
|
Cardiac - Tumor: |
Back to the top |
|
None selected this quarter.
|
|
Cerebral Protection and Stroke |
Back to the top |
|
The risk of stroke following CABG: one possible strategy to reduce it?
De Feo M, Renzulli A, Onorati F, et al.
Int J Cardiol 2005;98:261-66 .
|
|
Complications: |
Back to the top |
|
The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting.
Toumpoulis IK, Anagnostopoulos CE, DeRose JJ Jr, Swistel DG.
Chest 2005;127:464-71.
|
|
Congenital: |
Back to the top |
|
Assessment of left ventricular function long term after arterial switch operation for transposition of the great arteries by dobutamine stress echocardiography.
Hui L, Chau AKT, Leung MP, Chiu CSW, Cheung YF.
Heart 2005;91:68-72.
|
|
Coronary Disease: |
Back to the top |
|
The Coronary ArteryRevascularisation in Diabetes (CARDia) trial: Background, aims, and design.
Kapur A, Malik IS, Bagger JP, et al.
Am Heart J 2005;149:13-19.
Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials.
Cheng DC, Bainbridge D, Martin JE, Novick RJ; Evidence-Based Perioperative Clinical Outcomes Research Group
Anesthesiology 2005;102:188-203.
Early and late outcome of skeletonised bilateral internal mammary arteries anastomosed to the left coronary system.
Bonacchi M, Battaglia F, Prifti E, et al.
Heart 2005;91:195-202.
|
|
Economics of Cardiac Surgery : |
Back to the top |
|
Heart transplant and left ventricular assist device costs.
Digiorgi PL, Reel MS, Thornton B, Burton E, Naka Y, Oz MC.
J Heart Lung Transplant 2005;24;200-04.
|
|
Electrophysiology - Arrhythmias: |
Back to the top |
Linear cryoablation of the left atrium versus pulmonary vein cryoisolation in patients with permanent atrial fibrillation and valvular heart disease: correlation of electroanatomic mapping and long-term clinical results.
Gaita F, Riccardi R, Caponi D, et al.
Circulation 2005;111:136-4.
|
Endocarditis: |
Back to the top |
|
Endovascular Therapy: |
Back to the top |
Endovascular stent-graft treatment of aortic dissection: determinants of post-interventional outcome.
Eggebrecht H, Herold U, Kuhnt O, et al.
Eur Heart J 2005;26:489-97.
Endovascular treatment of thoracic aortic aneurysms: Results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis.
Makaroun MS, Dillavou ED, Kee ST, et al. and GORE TAG Investigators
J Vasc Surg 2005; 41:1-9.
|
Extracorporeal Circulation: |
Back to the top |
None selected this quarter.
|
Great Vessels: |
Back to the top |
Acute intramural hematoma of the aorta: a mystery in evolution.
Evangelista A, Mukherjee D, Mehta RH, et al; International Registry of Aortic Dissection (IRAD) Investigators.
Circulation 2005;111:1063-70.
|
Heart Failure - Congestive/Ischemic: |
Back to the top |
Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation.
Bursi F, Enriquez-Sarano M, Nkomo VT, et al.
Circulation 2005;111:295-301.
|
Mechanical Circulatory Support: |
Back to the top |
None selected this quarter.
|
Minimally Invasive Surgery: |
Back to the top |
None selected this quarter.
|
Molecular Biology: |
Back to the top |
Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance.
Yilmaz MB, Balbay Y, Caldir V, et al.
Thromb Res 2005;115:25-29.
|
Myocardial Infarction: |
Back to the top |
None selected this quarter.
|
Myocardial Protection: |
Back to the top |
None selected this quarter.
|
Pericardium: |
Back to the top |
None selected this quarter.
|
Peripheral Vascular: |
Back to the top |
Restenosis after carotid angioplasty, stenting, or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS).
McCabe DJH, Pereira AC, Clifton A, Bland JM, Brown MM; CAVATAS Investigators.
Stroke 2005;36:281-86.
|
Randomized Controlled Trials : |
Back to the top |
Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: A review of randomized controlled trials.
Okrainec K, Platt R, Pilote L, Eisenberg MJ.
J Am Coll Cardiol 2005; 45:177-84.
|
Transplantation - Heart: |
Back to the top |
Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry.
Wu AH, Ballantyne CM, Short BC, et al.
Am J Cardiol 2005;95:367–72.
Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies.
Pinney SP, Cheema FH, Hammond K, Chen JM, Edwards NM, Mancini D.
J Heart Lung Transplant 2005; 24:34-37.
|
Trauma: |
Back to the top |
None selected this quarter.
|
Valve Disease: |
Back to the top |
Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years.
Agarwal A, Kini AS, Attanti S, et al.
Am J Cardiol 2005;95:43–47.
Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: Implications for end-stage valvular heart disease.
Wu B, Elmariah S, Kaplan FS, Cheng G, Mohler ER III.
Arterioscler Thromb Vasc Biol 2005;25:592-97.
Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty.
Fukuda S, Song JM, Gillinov AM, et al.
Circulation 2005;111:975-79.
|
Vascular: |
Back to the top |
|
Print
E-Mail
Facebook
Twitter
Sharethis